Navigation Links
At 30, biotech is an industry at a crossroads

So just how old is the biotech industry? The July 2006 edition of MedAd News sustains that the industry has hit its 30th birthday this year. On Aug, 23, 2004, I wrote an article for this publication on "The Birth of Biotech: San Francisco, Boston, Geneva, or Chicago?"

In this ar......

Full article >>> llion, which grew 18 percent over the prior year (remember that the entire pharmaceutical industry grew 7 percent last year, and 5 percent in North America).
  • Losses of $4.3 billion, which decreased 30 percent from the prior year.
  • 32 new product approvals in the U.S., including 17 first-time approvals.
  • The second highest year for raising capital......

    Full article >>> companies.
  • Focus of cancer drugs on tumor types rather than tumor location: This dynamic is changing treatment modality in oncology. There are over 400 cancer drugs in development, and this development is changing how oncology clinical trials are being conducted. For example, it is not enough to say a patient has lung cancer today, as there are two broad types of lung can......

    Full article >>> nentech (U.S. - 1976)$6,633+44%$1,279+63%3. Genzyme (U.S. - 1981 )$2,735+24%$442+408%4. Serono (Switzerland - 1906 )**$2,586+5%<$105>N/A5. CSL (Australia - 1961)**$2,494+77%$419+149%6.......

    Full article >>> td>+49%22.Enzon Pharmaceuticals (U.S. - 1981)$166<2%><$90>N/A23.Vertex Pharmaceuticals (U.S. - 1989)$161+56%<$203><22%>24.Amylin Pharmaceuticals (U.S. - 1987)$141+315%<$207><32%>25.Berna Biotech (Switzerland - 1898)**
    Full article >>> 006

    Clearly, Amgen and Genentech are spending prodigious R&D sums, comparable to Big Pharma levels, but the next 3 yo 4 companies are not too far behind. This R&D is the life blood of a biotech company.

    All of the above trends noted by MedAd News really only focus on the drug part of biotech. As a result, I would add the following trends:



    Source:wistechnology.com By Michael Rosen 08/01/06


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Olympics of biotechnology has international flavor
    3. Getting noticed in Genetown: Wisconsin biotech on display
    4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
    5. Wisconsin biotech firm receives $107K NIH grant
    6. Manufacturing partnership will move into biotech and biomedical spaces
    7. Wisconsin wont get Georgia biotech without a fight
    8. The 10 biggest events shaping biotech in 2006
    9. NimbleGen partners with UK biotech firm
    10. 2006: A great biotech financing year, unless you were going public!
    11. Big pharma seeks Wisconsin biotech partnerships
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/11/2016)... Feb. 11, 2016  Bioethics International, a not-for-profit organization focused ... developed, marketed and made accessible to patients around the world, ... had named the publication of the Good Pharma Scorecard ... is also featured as one of BMJ Open ,s ... year that are most frequently read. Ed Sucksmith ...
    (Date:2/11/2016)... 11, 2016 --> ... "Company") (OTCQB: PSID), a life sciences company focused ... Thermomedics subsidiary, which markets the Caregiver® FDA-cleared non-contact ... in January 2016, including entering into agreements with ... sales growth, and establishing several near-term pipeline opportunities. ...
    (Date:2/10/2016)... - BioAmber Inc. (NYSE: BIOA ), a leader ... & Co. Ltd., its partner in the ... an additional CDN$25 million in the joint venture for ... to 40%.  Mitsui will also play a stronger role ... Sarnia , providing dedicated resources alongside BioAmber,s ...
    (Date:2/10/2016)... York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has ... develop new vaccines and immunotherapies for infectious diseases and cancer. , ...
    Breaking Biology Technology:
    (Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
    (Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
    (Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
    Breaking Biology News(10 mins):